Keping Xie[Author] - Search Results

Year	Number of Results
2001	2
2002	3
2003	9
2004	7
2005	11
2006	8
2007	6
2008	8
2009	7
2010	6
2011	6
2012	9
2013	9
2014	8
2015	14
2016	8
2017	5
2018	7
2019	4
2020	5
2021	3
2022	5
2023	13
2024	4

1

m⁶A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.

Zhang S, Zhao BS, Zhou A, Lin K, Zheng S, Lu Z, Chen Y, Sulman EP, Xie K, Bögler O, Majumder S, He C, Huang S. Zhang S, et al. Among authors: xie k. Cancer Cell. 2017 Apr 10;31(4):591-606.e6. doi: 10.1016/j.ccell.2017.02.013. Epub 2017 Mar 23. Cancer Cell. 2017. PMID: 28344040 Free PMC article.

2

KLF4 transcription factor in tumorigenesis.

He Z, He J, Xie K. He Z, et al. Among authors: xie k. Cell Death Discov. 2023 Apr 8;9(1):118. doi: 10.1038/s41420-023-01416-y. Cell Death Discov. 2023. PMID: 37031197 Free PMC article. Review.

3

A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma.

Zhang M, Zhao K, Xu X, Yang Y, Yan S, Wei P, Liu H, Xu J, Xiao F, Zhou H, Yang X, Huang N, Liu J, He K, Xie K, Zhang G, Huang S, Zhang N. Zhang M, et al. Among authors: xie k. Nat Commun. 2018 Oct 26;9(1):4475. doi: 10.1038/s41467-018-06862-2. Nat Commun. 2018. PMID: 30367041 Free PMC article.

4

Ductal metaplasia in pancreas.

Li S, Xie K. Li S, et al. Among authors: xie k. Biochim Biophys Acta Rev Cancer. 2022 Mar;1877(2):188698. doi: 10.1016/j.bbcan.2022.188698. Epub 2022 Feb 15. Biochim Biophys Acta Rev Cancer. 2022. PMID: 35176433 Review.

5

Acinar cells and the development of pancreatic fibrosis.

An J, Jiang T, Qi L, Xie K. An J, et al. Among authors: xie k. Cytokine Growth Factor Rev. 2023 Jun-Aug;71-72:40-53. doi: 10.1016/j.cytogfr.2023.05.003. Epub 2023 May 26. Cytokine Growth Factor Rev. 2023. PMID: 37291030 Review.

6

Senescence program and its reprogramming in pancreatic premalignancy.

Yang K, Li X, Xie K. Yang K, et al. Among authors: xie k. Cell Death Dis. 2023 Aug 17;14(8):528. doi: 10.1038/s41419-023-06040-3. Cell Death Dis. 2023. PMID: 37591827 Free PMC article. Review.

7

Pancreatic cancer.

Li D, Xie K, Wolff R, Abbruzzese JL. Li D, et al. Among authors: xie k. Lancet. 2004 Mar 27;363(9414):1049-57. doi: 10.1016/S0140-6736(04)15841-8. Lancet. 2004. PMID: 15051286 Review.

8

Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Ductal Adenocarcinoma.

Zhao T, Jiang T, Li X, Chang S, Sun Q, Kong F, Kong X, Wei F, He J, Hao J, Xie K. Zhao T, et al. Among authors: xie k. Clin Cancer Res. 2023 Dec 15;29(24):5183-5195. doi: 10.1158/1078-0432.CCR-23-1143. Clin Cancer Res. 2023. PMID: 37819952

9

Clinical significance of pancreatic ductal metaplasia.

Jiang T, Wei F, Xie K. Jiang T, et al. Among authors: xie k. J Pathol. 2022 Jun;257(2):125-139. doi: 10.1002/path.5883. Epub 2022 Mar 16. J Pathol. 2022. PMID: 35170758 Review.

10

Epigenetic reprogramming in pancreatic premalignancy and clinical implications.

Zhang W, Jiang T, Xie K. Zhang W, et al. Among authors: xie k. Front Oncol. 2023 Feb 16;13:1024151. doi: 10.3389/fonc.2023.1024151. eCollection 2023. Front Oncol. 2023. PMID: 36874143 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

150 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Results by year